Completed PHASE3 INTERVENTIONAL 2-arm NCT01601574

Weight Loss Study for People With Type 2 Diabetes (T2D)

Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes

Sponsor: Medical University of South Carolina

Conditions Obesity Overweight Type 2 Diabetes

Interventions Standard Care group Weight Watchers modified program

Updated 5 times since 2017 Last updated: Oct 14, 2014 Started: May 31, 2012 Primary completion: May 31, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Obesity and Overweight and is currently completed. Medical University of South Carolina leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
WW International Inc

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Augusta, United States , Birmingham, United States , Charleston, United States , Charlotte, United States , Chicago, United States , Dallas, United States , Durham, United States , La Jolla, United States , Mentor, United States and 4 more locations